NCT02055404

Brief Summary

The purpose of this study was to select the size of the molded rotation mark for a new toric contact lens by comparing the visibility of various molded rotation marks.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2013

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2013

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2013

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

February 4, 2014

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 5, 2014

Completed
2 months until next milestone

Results Posted

Study results publicly available

April 2, 2014

Completed
Last Updated

April 2, 2014

Status Verified

February 1, 2014

Enrollment Period

Same day

First QC Date

February 4, 2014

Results QC Date

February 20, 2014

Last Update Submit

February 20, 2014

Conditions

Keywords

astigmatismtoriccontact lensesdaily disposable contact lensesmolded markrotation mark

Outcome Measures

Primary Outcomes (1)

  • Visibility of Rotation Mark (Clearly Visible, Slightly Visible Acceptable)

    Each lens (containing 8 rotation marks and one reference mark, in total 9 marks) was assessed for visibility by 10 investigators using the following scale: "N/A;" "Not visible;" "Slightly visible, not acceptable;" "Slightly visible, acceptable;" "Clearly visible;" "More visible than necessary." Visibility assessments were made after all marks had been evaluated. S9 Mark (test lens) functioned as a starting marker only and was not rated. The control lens was not used as a comparison, but rather as a reference for what a mark looks like on a commercial product. "Visibility of Rotation Mark" is reported as the percentage of assessments rating the rotation mark as "Clearly visible" or "Slightly visible, acceptable."

    Day 1

Study Arms (2)

Delefilcon A

EXPERIMENTAL

Delefilcon A spherical contact lens with molded marks randomly assigned to one eye, with etafilcon A toric contact lens in the fellow eye for contralateral wear approximately 2 hours in duration

Device: Delefilcon A spherical contact lens with molded marks

Etafilcon A

OTHER

Etafilcon A toric contact lens randomly assigned to one eye, with delefilcon A spherical contact lens with molded marks in the fellow eye for contralateral wear approximately 2 hours in duration

Device: Etafilcon A toric contact lens

Interventions

Silicone hydrogel contact lens with 9 different molded marks of varying widths and depths indented into the front surface (S1, S2, S3, S4, S5, S6, S7, S8, and S9). Each lens contained all 9 marks.

Delefilcon A

Hydrogel toric contact lens for daily wear, daily disposable use

Also known as: 1-DAY ACUVUE® MOIST® for ASTIGMATISM
Etafilcon A

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Sign Informed Consent document.
  • Best corrected distance visual acuity (VA) greater than or equal to 20/25 in each eye.

You may not qualify if:

  • History of any ocular surgery or ocular injury within 12 weeks of study enrollment.
  • Any ocular disease, infection, inflammation, or abnormality that contraindicates contact lens (CL) wear.
  • History of herpetic keratitis.
  • Slit-lamp findings greater than grade 2 at baseline.
  • Any use of systemic or ocular medications for which CL wear could be contraindicated.
  • Inactive corneal neovascularization greater than 1 millimeter of penetration.
  • A clinically significant dry eye not responding to treatment.
  • History of refractive surgery.
  • Participation in a clinical study within the previous 30 days.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Refractive ErrorsAstigmatism

Condition Hierarchy (Ancestors)

Eye Diseases

Results Point of Contact

Title
Joachim Nick, Dipl. Ing.
Organization
Alcon Research, Ltd.

Study Officials

  • Joachim Nick, Dipl. Ing.

    Alcon Research

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 4, 2014

First Posted

February 5, 2014

Study Start

February 1, 2013

Primary Completion

February 1, 2013

Study Completion

February 1, 2013

Last Updated

April 2, 2014

Results First Posted

April 2, 2014

Record last verified: 2014-02